Would You Rather?: Goldman Sachs or The Mag7… And Structure Therapeutics CEO 1/15/26
CNBC's "Fast Money"
00:00
Obesity Drug Market Dynamics and M&A Potential
Panel assesses crowded obesity-pill race, 'best-in' strategies, and why Structure could be an acquisition target.
Play episode from 38:44
Transcript
